Bausch + Lomb Corporation (BLCO.TO) TSX

24.33

+0.27(+1.12%)

Updated at January 14 11:12AM

Currency In CAD

Bausch + Lomb Corporation

Address

520 Applewood Crescent

Vaughan, ON L4K 4B4

Canada

Phone

905 695 7700

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

13500

First IPO Date

May 06, 2022

Key Executives

NameTitlePayYear Born
Brenton L. SaundersCEO & Chairman6.83M1970
Andrew StewartPresident of Global Pharmaceuticals & International Consumer1.65M1976
Yehia HashadExecutive VP of Research & Development and Chief Medical officer1.86M1967
A. Robert D. BaileyExecutive VP & Chief Legal Officer2.03M1963
Osama A. EldessoukyExecutive VP & CFO2.22M1972
Manisha A. NarasimhanChief Corporate Development & Digital Officer01977
Alan WaterhouseExecutive VP and Chief Supply Chain & Operations Officer01960
Frederick J. MunschSenior Vice President, Controller & Chief Accounting Officer01971
George GadkowskiVice President & Head of Investor Relations & Business Insights0N/A
Jonathon L. KellermanChief Compliance Officer0N/A
CrawfordChief Communications Officer0N/A

Description

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.